Package 65219-259-55

{"route": ["INTRAVENOUS"], "spl_id": "35f3281c-1865-4958-ae33-acdfbf8b1b28", "openfda": {"unii": ["M98T69Q7HP", "UXA545ABTT"], "rxcui": ["1659149"], "spl_set_id": ["b9bd733c-1176-42cb-b318-1223b7e48dcb"], "manufacturer_name": ["Fresenius Kabi USA, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL, SINGLE-USE in 1 CARTON (65219-259-55)  / 20 mL in 1 VIAL, SINGLE-USE (65219-259-15)", "package_ndc": "65219-259-55", "marketing_start_date": "20210524"}], "brand_name": "Piperacillin and Tazobactam", "product_id": "65219-259_35f3281c-1865-4958-ae33-acdfbf8b1b28", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Penicillin-class Antibacterial [EPC]", "Penicillins [CS]", "beta Lactamase Inhibitor [EPC]", "beta Lactamase Inhibitors [MoA]"], "product_ndc": "65219-259", "generic_name": "Piperacillin and Tazobactam", "labeler_name": "Fresenius Kabi USA, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Piperacillin and Tazobactam", "active_ingredients": [{"name": "PIPERACILLIN SODIUM", "strength": "4 g/20mL"}, {"name": "TAZOBACTAM SODIUM", "strength": ".5 g/20mL"}], "application_number": "ANDA203719", "marketing_category": "ANDA", "marketing_start_date": "20210524", "listing_expiration_date": "20261231"}